Deep Neural Network (DNN) stands for multilayered Neural Network (NN) that is capable of progressively learn the more abstract and composite representations of the raw features of the input data received, with no need for any feature engineering. They are advanced NNs having repetitious hidden layers between the initial input and the final layer. The working principle of such a standard deep classifier is based on a hierarchy formed by the composition of linear functions and a defined nonlinear Activation Function (AF). It remains uncertain (not clear) how the DNN classifier can function so well. But it is clear from many studies that within DNN, the AF choice has a notable impact on the kinetics of training and the success of tasks. In the past few years, different AFs have been formulated. The choice of AF is still an area of active study. Hence, in this study, a novel deep Feed forward NN model with four AFs has been proposed for breast cancer classification: hidden layer 1: Swish, hidden layer, 2:-LeakyReLU, hidden layer 3: ReLU, and final output layer: naturally Sigmoidal. The purpose of the study is twofold. Firstly, this study is a step toward a more profound understanding of DNN with layer-wise different AFs. Secondly, research is also aimed to explore better DNN-based systems to build predictive models for breast cancer data with improved accuracy. Therefore, the benchmark UCI dataset WDBC was used for the validation of the framework and evaluated using a ten-fold CV method and various performance indicators. Multiple simulations and outcomes of the experimentations have shown that the proposed solution performs in a better way than the Sigmoid, ReLU, and LeakyReLU and Swish activation DNN in terms of different parameters. This analysis contributes to producing an expert and precise clinical dataset classification method for breast cancer. Furthermore, the model also achieved improved performance compared to many established state-of-the-art algorithms/models.
Medical data classification is the process of transforming descriptions of medical diagnoses and procedures into universal medical code numbers. The diagnoses and procedures are usually taken from a variety of sources within the healthcare record, such as the transcription of the physician’s notes, laboratory results, radiologic results and other sources. However, there exist many frequency distribution problems in these domains. Hence, this paper intends to develop an advanced and precise medical data classification approach for diabetes and breast cancer dataset. With the knowledge of the features and challenges persisting with the state-of-the-art classification methods, deep learning-based medical data classification methodology is proposed here. It is well known that deep learning networks learn directly from the data. In this paper, the medical data is dimensionally reduced using Principle Component Analysis (PCA). The dimensionally reduced data are transformed by multiplying by a weighting factor, which is optimized using Whale Optimization Algorithm (WOA), to obtain the maximum distance between the features. As a result, the data are transformed into a label-distinguishable plane under which the Deep Belief Network (DBN) is adopted to perform the deep learning process, and the data classification is performed. Further, the proposed WOA-based DBN (WOADBN) method is compared with the Neural Network (NN), DBN, Generic Algorithm-based NN (GANN), GADBN, Particle Swarm Optimization (PSONN), PSO-based DBN (PSODBN), WOA-based NN (WOANN) techniques and the results are obtained, which shows the superiority of proposed algorithm over conventional methods.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.